RELATED: State identifies medical pot applicants
Aphria co-founder Cole Cacciavillani said in an interview this week the company — if granted a license in Ohio — would operate under the newly formed business Liberty Health Science, which went live today on the Canadian Stock Exchange.
“I don’t think you could’ve found a better partner than the Schottenstein family in Ohio,” he said.
He said they hope to put their indoor growing facility outside of Amherst in Lorain County to be close to their Canadian operations.
RELATED: Ohio to buy $6 million seed-to-sale marijuana tracking system
Cacciavillani said his company — which operates in Canada and Florida, and is setting up operations in Arizona — partnered with the Schottenstein family because of its knowledge of the retail industry and familiarity with the Ohio market.
“Combined, we could be a really strong entity,” he said.
Messages left for a spokesman of the Schottenstein Store Corporation were not returned.
Aphria is one of several major players in the North American medical marijuana market looking to stake a claim in Ohio, where nearly a quarter of the state’s 11.6 million residents could qualify to receive medical cannabis.
RELATED COVERAGE
About the Author
